a transcription factor of the basic-helix-loop-helixleucine zipper family, a middle segment of approxiJoseph L. Goldstein, and Michael S. Brown mately 75 amino acids composed of two membraneDepartment of Molecular Genetics spanning regions separated by a short hydrophilic loop University of Texas Southwestern Medical Center of 31 amino acids, and a carboxy-terminal segment of Dallas, Texas 75235 approximately 500 amino acids that plays a regulatory role (Yokoyama et al., 1993; Hua et al., 1993) . The SREBPs are oriented in the membranes of the endoplasSummary mic reticulum (ER) and nuclear envelope in a hairpin fashion, so that the NH 2 -terminal and carboxy-terminal Through expression cloning we have isolated a cDNAsegments project into the cytosol and the 31 amino acid encoding SREBP cleavage-activating protein (SCAP), loop projects into the lumen (Hua et al., 1995). In cultured which regulates cholesterol metabolism by stimulatcells the two SREBPs act independently, and they are ing cleavage of transcription factors SREBP-1 and -2, apparently redundant. thereby releasing them from membranes. The cDNA
. Immunoblot Analysis of SREBP-1 and SREBP-2 in Wild-Type CHO-7 Cells and Mutant 25-RA Cells On day 0, cells were set up for experiments as described in Experimental Procedures. On day 2, the medium was changed to medium B containing 5% newborn calf lipoproteindeficient serum, 50 M sodium mevalonate, and 50 M compactin, supplemented with the indicated concentration of 25-HC. On day 3, cells were harvested and fractionated into a nuclear extract and 10 5 g membrane pellet (Sakai et al., 1996) . Aliquots (60 g protein) were subjected to SDS-PAGE. Immunoblot analysis was carried out with 5 g/ml of either IgG-2A4 (A) or IgG-7D4 (B). Filters were exposed to film for 2 min (A) and 20 s (B). P and M denote precursor and mature forms of SREBP-1 or SREBP-2, respectively. derived cholesterol or with hydroxylated sterols such and Chang, 1994) . Building upon this observation, we designed an expression-cloning strategy to identify the as 25-hydroxycholesterol (25-HC; Chang and Limanek, 1980; Metherall et al., 1989) . The sterol-resistant cells mutant gene in the 25-RA cells. We show that the phenotype is caused by a gain-of-function point mutation in can be divided into two classes. Class 1 cells are sterolresistant because they produce a truncated form of a gene encoding a novel membrane protein that we call SCAP (SREBP cleavage-activating protein). The mutant SREBP-2 that contains the complete NH 2 -terminal segment but terminates before the membrane attachment SCAP activates cleavage of SREBP at site 1, and it renders the reaction resistant to suppression by sterols. domain (Yang et al., , 1995 . The truncated protein goes directly to the nucleus without a requirement for Although wild-type SCAP can exert the same effect when overexpressed by transfection, the mutant form proteolysis, and therefore it cannot be suppressed by sterols. A set of three independent class 1 mutants have is much more active. The mutation that activates SCAP is a G→A transition that changes codon 443 from asparbeen studied, and each was shown to result from a recombination in the intron that immediately follows cotic acid to asparagine. SCAP is a membrane protein with multiple membrane-spanning segments, some of which don 460 in the SREBP-2 gene (Yang et al., , 1995 . Each recombination involves a different site in the large show a highly significant resemblance to the membranespanning segments of HMG CoA reductase, an enzyme 3100 bp intron, but each has the same effect, namely, to produce a form of SREBP-2 that lacks the membrane whose degradation is regulated by sterols. attachment domain. SREBP-1 is structurally normal in the class 1 cells, but its proteolytic processing is reResults duced, apparently through a regulatory effect exerted by the constitutively truncated SREBP-2. Figure 1 shows immunoblots of nuclear extracts and membrane fractions from wild-type CHO-7 cells and We have recently described a second class of sterolresistant mutant CHO cells (Cao et al., 1996) . These class 25-RA cells grown in the absence of sterols or in the presence of varying amounts of 25-HC. The filters were 2 mutant cells produce normal full-length SREBP-1 and SREBP-2, and they proteolyze them normally, but they blotted with antibodies against SREBP-1 ( Figure 1A ) or SREBP-2 ( Figure 1B ). In the wild-type CHO cells, cannot turn off this proteolysis in response to sterol overload. The first such line, designated SRD-4 cells, concentrations of 25-HC as low as 0.1 g/ml caused a disappearance of the NH 2 -terminal fragments of both was found to have two independent defects: first, an inability to turn off the proteolysis of SREBPs; and secSREBPs from the nuclear extract. We have previously shown that this disappearance is caused by an inhibition ond, a point mutation in the gene encoding acylCoA:cholesterol acyltransferase (ACAT), which abolof cleavage at site 1 (Sakai et al., 1996) . In the steroltreated 25-RA cells, the nuclear form of SREBP-1 was ishes enzyme activity (Cao et al., 1996) . Transfection of a cDNA encoding wild-type ACAT corrected the enzyme only slightly reduced, even at 1 g/ml of 25-HC ( Figure  1A) . A similar 25-HC resistance was observed for the deficiency, but it did not restore regulation of the proteolytic processing of the SREBPs, confirming that the two nuclear form of SREBP-2 in the 25-RA cells ( Figure 1B ). These data demonstrate that the 25-RA cells, like the defects are independent.
In the current studies, we identify the molecular defect previously described SRD-4 cells (Cao et al., 1996) , are resistant to the effect of 25-HC in suppressing the cleavin one line of class 2 sterol-resistant CHO cells, namely the 25-RA cells isolated by Chang and Limanek (1980) . age of both SREBPs. Based on the prior evidence that the defect in the Like the SRD-4 cells, the 25-RA cells manifest defective sterol-resistant SREBP processing, but they do not have 25-RA cells is dominant (Hasan and Chang, 1994) , we developed an expression-cloning strategy to identify the a defect in ACAT. Hasan and Chang (1994) showed that the phenotype of the 25-RA cells is semidominant. When mutant gene. A cDNA library was prepared from 25-RA cells in an expression vector that uses the cytomegalovithey fused 25-RA cells to wild-type CHO cells, the resultant hybrids were partially resistant to 25-HC (Hasan rus (CMV) promoter. The cDNAs were divided into pools of about 1,000 each and transfected into human kidney 293 cells, together with a reporter gene encoding luciferase under control of a promoter that contains three copies of a sterol regulatory element (SRE-1) in tandem with three copies of a weak binding site for the ubiquitous transcription factor Sp1. This configuration, which is based on the LDL receptor promoter/enhancer elements, has been shown to yield high level expression that is dependent on nuclear SREBPs (Briggs et al., 1993) . After transfection, the 293 cells were incubated in the presence of 25-HC, which suppresses luciferase transcription by inhibiting the proteolytic release of SREBPs. As a control for variations in transfection efficiency, we also cotransfected a plasmid encoding ␤-galactosidase under control of the nonregulated SV40 promoter. If the 293 cells express a cDNA that abolishes 25-HC-mediated suppression, the result should be an increase in the ratio of luciferase to ␤-galactosidase activity. This ratio is hereafter designated as "normalized" luciferase activity. Figure 2A shows a result of one transfection experiment using a subset of the cDNA pools from the 25-RA library. Normalized luciferase activity was low in all cases except for cells that received cDNA from pool 60. This pool of 1,000 plasmids was subfractionated into subpools of about 100 plasmids each, and two positive subpools were detected ( Figure 2B ). We chose one of these (subpool 60-19) and further fractionated it into subpools of approximately 10 colonies each. Again, two positive subpools were identified, and we chose subpool 60-19-42 ( Figure 2C ). Further fractionation steps yielded subpool 60-19-42-23 ( Figure 2D ) and finally two pure cDNA clones designated p28 and p30 ( Figure 2E ).
Partial sequence analysis of plasmids p28 and p30 indicated that they encoded the same protein, and we chose to study plasmid p30 in detail. Plasmid p30 contains a cDNA insert of 4.2 kb. Northern blot analysis showed a single 4.2 kb band in the RNA from both CHO-7 and 25-RA cells (data not shown). Complete sequence analysis revealed that this insert encodes a full-length copy of a 1276 amino acid protein that we named SCAP. The insert also contains 119 bp of 5Ј-untranslated region and approximately 150 bp of 3Ј-untranslated region, including a long poly(A) ϩ sequence. While the current studies were in progress, Nagase et of hamster SCAP, which they isolated as one of 40 unidentified coding sequences from a cDNA library preprotein (Wilson et al., 1994) . The hamster and human pared from myeloblast KG-1 cells. Figure 3 compares proteins are 92% identical, and the C. elegans protein is the sequences of hamster SCAP (this study), human SCAP (Nagase et al., 1996) , and the related C. elegans 26% identical to that of the hamster. Regions of identity extend throughout the sequence. We found two differences between the sequence of the wild-type hamster cDNA and the cDNA isolated from 25-RA cells. The first was a G→A transition in codon 443, which changes the wild-type aspartic acid to an asparagine in the 25-RA cDNA (indicated by an asterisk in Figure 3 ). This aspartic acid is conserved in the human and C. elegans sequences. The second difference was a G→A transition in codon 816, which changed a glycine to arginine. Analysis of genomic DNA from wild-type CHO-7 and CHO-K1 cells, as well as from mutant 25-RA cells, showed that all three cell lines were heterozygous at this site (data not shown), suggesting that it represents a silent polymorphism. We therefore directed our attention to the D443N mutation.
To confirm the mutation at codon 443 in the 25-RA cells, we amplified the genomic sequence that includes this codon from genomic DNA and cut the amplified products with PvuI. The wild-type sequence is expected to be cut with this enzyme, while the mutant should be resistant ( Figure 4A ). Figure 4B shows that the amplified product from wild-type CHO cells (CHO-K1 cells) was completely cut with PvuI, whereas only about 50% of the amplified product from the 25-RA cells was cut. This result indicates that the 25-RA cells, but not the parental CHO cells, are heterozygous for the D443N mutation. Sequencing of the polymerase chain reaction (PCR) product confirmed the D443N mutation.
The mutation in the 25-RA cells was also apparent when we analyzed genomic DNA by single-strand conformational polymorphism analysis ( Figure 4C ). This analysis showed an extra band in the 25-RA DNA, confirming that these cells are heterozygous for a mutation in the amplified region.
To demonstrate that SCAP(D443N) stimulates the cleavage of SREBPs and to determine whether it acts at site 1 or 2, we tested the ability of the protein to stimulate the cleavage of wild-type and mutant forms of SREBP-2 in cells that were treated with sterols. Plasmids encoding SCAP(D443N) and an epitope-tagged version of SREBP-2 were introduced into 293 cells by transfection, and the amount of the nuclear NH2-terminal fragment of SREBP-2 was measured by immunoblotting with an antibody against the NH 2 -terminal epitope tag ( Figure 5 ). As expected, 25-HC caused the NH 2 -terminal fragment to disappear from the nuclear extract (upper panel, lane 4). SCAP(D443N) prevented this disappearance (lane 6). In this experiment, we also observed a small amount of the membrane-bound intermediate form that results from cleavage at site 1 but not site 2
Identical residues in at least two of the three sequences are highlighted in black. The dot over codon 816 in the hamster sequence denotes a DNA polymorphism (GGG/AGG; glycine/arginine) found in wild-type CHO-7 and CHO-K1 cells. The asterisk at codon 443 in the hamster SCAP sequence denotes the mutation in the 25-RA cells (GAC→AAC; Asp→Asn). Boxed sequences denote WD repeats; X's denote the most highly conserved residues (Neer et al., 1994) . Sequences for human K1AA0199 (Nagase et al., 1996 ; GenBank accession number D83782) and C. elegans D2013.8 (Wilson et al., 1994 ; GenBank accession number 247808) were obtained from the (final concentration of 25 g/ml) for an additional 4 hr, after which (B) PvuI digestion of PCR products amplified from SCAP gene.
cell fractionation was carried out as described (Sakai et al., 1996) . Genomic DNA from CHO-K1 (lanes 1 and 2) and 25-RA (lanes 3 and Aliquots of protein (50 g of nuclear extract or 60 g of membranes) 4) cells was subjected to PCR with primers 2 and 4 corresponding were subjected to SDS-PAGE and immunoblot analysis with 0.5 g/ to amino acids 426-432 (5Ј-TGTCTGACTTCTTCCTCCAG-3Ј) and ml of IgG-HSV•Tag TM . Filters were exposed for 1 min. M, P, and I 467-473 (5Ј-GCGTGCTGGCCTTCCCACAGG-3Ј), respectively. PCR denote the mature, precursor, and intermediate forms of SREBP-2, was carried out in 50 mM Tris-HCl (pH 9.1), 16 mM (NH 4)2SO4, 3.5 respectively. mM MgCl 2, 0.15 mg/ml of bovine serum albumin, 125 M dNTP, 100 nM primers, and 0.5 mCi/ml [ 32 P]dCTP with 0.1 U/l of Klentaq polymerase and 6 ϫ 10 Ϫ4 U/l of Pfu polymerase at 95ЊC for 5 min, ability to stimulate cleavage of the R519A mutant of followed by 30 cycles at 94ЊC for 30 s, 62ЊC for 30 s, and 72ЊC for SREBP-2, which fails to undergo cleavage at site 1, 30 s. Aliquots of the PCR products were incubated at 37ЊC for 24
owing to the elimination of the lumenal arginine (lanes hr in the absence or presence of PvuI, as indicated. The treated 13 and 14). Considered together, the data of Figure 5 DNA was separated on a 7% polyacrylamide gel containing 10% glycerol and exposed to film for 7 hr at room temperature. 3) . The gel was subjected tein, and SREBP expression was driven by the thymidine to electrophoresis at 300 volts for 22 hr at room temperature, dried, kinase (TK) promoter, which gives a low level of expresand exposed to film for 10 hr at Ϫ70ЊC. The amplified 162 bp PCR product contained 96 bp of the SCAP cDNA sequence, followed by sion that is similar to the amount normally expressed in 66 bp of the intron sequence. Arrows denote single-strand DNA these cells . The cells were incubated in from wild-type or mutant (D443N) SCAP gene.
the presence of 25-HC, and the amounts of the epitopetagged NH2-terminal fragments in the nuclear extract were measured ( Figure 6 , upper panels). We also esti-(lower panel, lane 3). This intermediate was abolished mated the amount of expressed SCAP by immunoblotby sterols (lane 4), and SCAP(D443N) prevented this ting with an antibody against the T7 epitope tag (lower disappearance (lane 6). We also studied the D468 panels). Expression of both SCAPs was driven by the RSR→AS mutant of SREBP-2, which is resistant to weak TK promoter, thereby allowing us to compare the cleavage at site 2 (Sakai et al., 1996) . SCAP(D443N) effects of graded amounts of SCAP-wt and SCAP stimulated cleavage of this mutant at site 1, and the (D443N). At a low level of SCAP expression (0.05 g resultant intermediate form accumulated in the memof plasmid transfected), SCAP(D443N) was much more brane fraction (lower panel, lanes 9 and 10) but not in potent than SCAP-wt in increasing the amount of nuclear SREBP-1a or -2 ( Figures 6A and 6B , upper panels). the nucleus (upper panel). SCAP(D443N) had much less On day 2 of growth, 293 cells were cotransfected with either 4.8 g of pTK-HSV-BP1a encoding HSV epitopetagged SREBP-1a (A) or 4.8 g of pTK-HSV-BP2 (B) and the indicated amount of plasmid encoding T7 epitope-tagged SCAP-wt or SCAP(D443N). The total amount of DNA was adjusted to 5 g/dish with pTK . All cells were cultured under suppressing conditions (1 g/ml of 25-HC plus 10 g/ml of cholesterol). On day 3, the cells were treated with ALLN for 4 hr before harvest and fractionation as described in Figure 5 . Aliquots of protein (50 g of nuclear extract or 60 g of membranes) were subjected to SDS-PAGE and immunoblotted with either 0.5 g/ml of IgG-HSV•Tag TM directed against epitope-tagged SREBP-1a and -2 (top) or 1 g/ml of IgG-T7• Tag   TM antibody directed against SCAP (bottom), followed by 0.5 Ci/ml of 125 I-labeled sheep anti-mouse whole antibody (Amersham). Filters were exposed for 16 hr to an imaging plate at room temperature and scanned in a Fuji X Bas 1000 Phosphoimager and the image photographed. Similar results were obtained in two other independent experiments. This was true even though the level of expression of encoding either wild-type or mutant SCAP under control wild-type and mutant SCAP were similar, as judged by of the TK promoter. Both plasmids also encoded neo, immunoblotting against the T7 epitope tag (lower pana gene that confers G418 resistance. The cells were els). At higher levels of SCAP expression, SCAP-wt then grown in the presence of G418 to select for showed distinct activity, especially in stimulating the transfected cells. A set of 12 independent colonies of cleavage of SREBP-1a ( Figure 6A, lanes 5 and 7) . Neversurvivors were plated in individual wells and grown in theless, the mutant SCAP remained more potent, even medium containing lipoprotein-deficient serum plus 0.3 at the highest amount of plasmid (0.2 g). Scanning of g/ml of 25-HC. After 6 days, all of the cells that were the filters in a Fuji Phosphoimager indicated that at the transfected with the control plasmid died (Figure 8 , left lowest level of SCAP expression (0.05 g of plasmid panel). Half of the 12 colonies transfected with the transfected), the SCAP(D443N) mutant was greater than SCAP-wt plasmid survived (middle panel), whereas all 10-fold more potent than SCAP-wt in stimulating cleavof the 12 colonies transfected with the mutant age of both SREBPs. At higher levels of expression, the SCAP(D443N) plasmid survived (right panel). We conrelative difference declined to 3-4-fold.
clude that overexpression of either SCAP-wt or SCAP We next attempted to determine whether SCAP-wt participates in the normal cleavage of SREBPs that occurs in the absence of sterols. For this purpose, we used a strategy in which we overexpressed the SREBPs by transfection with a plasmid containing the strong CMV promoter. We have shown previously that such overexpressed SREBPs are cleaved inefficiently, apparently owing to the saturation of a rate-limiting component . To determine whether that component is SCAP, we cotransfected cDNAs encoding wild-type SCAP or SCAP(D443N) together with a plasmid encoding epitope-tagged SREBP-2 under control of the CMV promoter. As shown in Figure 7 , in the absence of SCAP, there was relatively little mature form of SREBP-2 in the nuclear extract either in the absence or presence of sterols (upper panel, lanes 1 and 2). Coexpression of SCAP-wt led to a marked stimulation of cleavage in the absence of sterols (lane 3), and there was only a slight type CHO cells with a control plasmid or a plasmid ER by means of a hydrophobic NH2-terminal domain of approximately 339 amino acids (Liscum et al., 1985) that is currently believed to contain eight membranespanning regions Roitelman et al., 1992) . A segment of HMG CoA reductase that includes membrane-spanning regions 2-6 shows 25% identity and 55% similarity to a corresponding region in the hydrophobic domain of SCAP (residues 280-444). The resemblance includes the hydrophilic loops between membrane-spanning regions 3-4 and 4-5 of HMG CoA reductase. Asp-443 of SCAP is included in the region of resemblance, but its position is occupied by a The database search also revealed that the hydroOn day 0, CHO-7 cells were set up at 5 ϫ 10 5 cells/100 mm dish in philic carboxy-terminal domain of SCAP contained four medium B supplemented with 5% newborn calf lipoprotein-deficient copies of a motif called the WD repeat (Neer et al., 1994) .
serum. On day 1, the cells were transfected with 10 g/dish of a These are indicated in Figure 3 , and their significance control plasmid pTK ; left), wild-type plasmid pTKis discussed below.
HSV-SCAP-T7 (middle), or mutant plasmid pTK-HSV-SCAP-T7(D443N) (right), using an MBS Kit (Stratagene). The cells were incubated with DNA for 3 hr in a 5% CO 2 incubator at 35ЊC and then refed with medium B with 5% newborn calf lipoprotein-deficient Discussion serum. On day 3, the cells were switched to medium containing 700 g/ml of G418. The medium was changed every 2-3 days. On day 16,
In the current studies, we used an expression-cloning individual colonies were isolated with cloning cylinders and grown in technique to isolate a cDNA encoding a superactive cloning strategy made use of the observation that 25-HC suppresses luciferase activity in human 293 cells transfected with a luciferase cDNA under control of a (D443N) can protect cells against lethal suppression by 25-HC.
promoter containing multiple copies of SRE-1. A transfected pool of cDNAs from the 25-RA cells was observed A hydropathy plot of the sequence of hamster SCAP revealed that the NH 2 -terminal 800 residues contained to block this sterol-mediated repression, and the responsible cDNA was isolated by repeated fractionation multiple long hydrophobic segments of at least 20 residues each ( Figure 9A ). We estimate that these segments of the pool. The mutant SCAP differs from SCAP-wt by virtue of might specify up to 10 membrane-spanning regions. The sequence also contains five potential N-linked glycosyla G→A transition at codon 443, which changes the Asp codon to Asn. In transient transfection experiments, muation sites that are indicated by the arrows in Figure  9A . To confirm the postulated membrane localization of tant SCAP prevented 25-HC from suppressing cleavage of wild-type SREBP-1a and -2. It also stimulated the SCAP, we transfected 293 cells with an HSV epitopetagged version of SCAP(D443N), and the cells were cleavage of the D484RSR→AS mutant of SREBP-2, but not the R519A mutant, indicating that SCAP stimulates fractionated into crude nuclear extract, cytosol, and membrane fractions. The fractions were subjected to cleavage at the first sterol-regulated site. In experiments to be reported in detail elsewhere SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting with the antibody against the HSV (Nohturfft et al., 1996) , we observed the identical G→A transition at codon 443 of SCAP in two other CHO cell epitope tag. All of the tagged SCAP was found in the membrane fraction ( Figure 9B ). Similar results were oblines that were mutagenized and selected for 25-HC resistance. By haplotype analysis, we showed that these tained with wt-SCAP.
In a search of databases for proteins that resembled mutations were indeed independent because they occurred on different parental chromosomes. We believe, SCAP, we found a significant resemblance to HMG CoA reductase, an ER-bound enzyme of the cholesterol biotherefore, that the D443N substitution is a highly specific event that endows SCAP with the ability to resist 25-synthetic pathway (Goldstein and Brown, 1990) . A similar relationship had been noted by Wilson et al. (1994) HC inhibition.
In the presence of 25-HC, SCAP-wt stimulated the with the C. elegans SCAP homolog, whose function was then unknown. Figure 9C compares the sequences of cleavage of SREBP-1a and -2. At very low levels of expression, the D443N mutant was at least 10-fold more hamster SCAP and hamster HMG CoA reductase in the areas of highest identity. The catalytic component of potent than the wild-type, but at high levels of expression the difference diminished. The difference nearly HMG CoA reductase consists of approximately 548 amino acids at the carboxy-terminus of the protein (Lisdisappeared when SCAP expression was driven by the CMV promoter, which gives much higher expression cum et al., 1985) . It is bound to the membranes of the (A) The residue-specific hydropathy index was calculated over a window of 20 residues by the method of Kyte and Doolittle (1982) , using the Genetics Computer Group Sequence Analysis Software Package, Version 8.0 (Devereux et al., 1984) . Arrows denote potential N-linked glycosylation sites. The solid bar denotes a region that resembles homology to transmembrane domains 2-6 in mammalian HMG CoA reductase (see [C] ). (B) 293 cells were transfected with 5 g/dish of either pBluescript ® II SK (lanes 1-3) or pTK-HSV-SCAP-T7(D443N), an HSV epitope-tagged plasmid encoding SCAP(D443N) (lanes 4-6). Transfected cells were incubated in medium A supplemented with 10% fetal calf serum for 16 hr and fractionated into nuclear extract, cytosol, and membrane fractions as described (Sakai et al., 1996) . Aliquots of protein from transfected cells (40 g for nuclear extract, lanes 1 and 4; 60 g for cytosol, lanes 2 and 5; and 60 g for membrane fraction, lanes 3 and 6) were subjected to SDS-PAGE and immunoblot analysis with 0.5 g/ml of IgG-HSV•Tag TM antibody. The filter was exposed to film for 30 s. (C) Identical residues are highlighted in black. Similar residues are denoted by an asterisk. Overbars denote position of membrane-spanning regions 2-6 in Chinese hamster HMG CoA reductase (Liscum et al., 1985; Olender and Simoni, 1992) . The sequence for HMG CoA reductase (GenBank accession number 123341) was from Chin et al. (1984) .
than the TK promoter (data not shown). We believe that the reaction at least partially resistant to inhibition by 25-HC. The sterol resistance may be attributable to massive the 10-fold difference observed at low levels of expression represents the true difference in potency of the two SCAP overexpression. If sterols inhibit SCAP activity by less than 100%, the residual SCAP activity in the proteins at their usual level of expression in cells. This difference accounts for the ability of 25-RA cells, but overexpressing cells may be sufficient to activate SREBP cleavage even in the presence of sterols. The not CHO-7 cells, to grow in the presence of 25-HC.
A role for SCAP-wt in the normal processing of D443N mutation renders the SCAP reaction resistant to inhibition by sterols, even at low physiologic levels of SREBPs is suggested by the experiment of Figure 7 . When we overexpressed SREBP-2 by transfection under SCAP expression, thereby explaining the sterol resistance phenotype of the 25-RA cells. control of the strong CMV promoter, the protein was cleaved inefficiently, suggesting that a required compo-
The hypothesis that SCAP is a normal part of the sterol-sensing machinery is supported by the finding of nent had become rate-limiting. When we overexpressed either SCAP-wt or SCAP(D443N), cleavage was stimusequence resemblance between the hydrophobic regions of SCAP and HMG CoA reductase. The original lated, both in the absence and presence of sterols. A possible explanation is that cleavage of SREBPs norcloning of HMG CoA reductase revealed that the protein was divided into two regions (Chin et al., 1984) . The mally requires SCAP and that sterols block cleavage of SREBPs by inhibiting the activity of SCAP. When catalytic domain at the carboxy-terminus is anchored to the membranes of the ER by a hydrophobic NH 2 -SREBPs are overexpressed, SCAP becomes saturated, and therefore cleavage is inefficient. Overexpression of terminal domain that was originally postulated to contain seven transmembrane segments (Liscum et al., 1985) . SCAP-wt restores efficient cleavage, and it also renders More recent data indicates that the true number is eight It is also possible that SCAP, like the ␤ subunit of the heterotrimeric G proteins, interacts with a GTP-binding Roitelman et al., 1992) . When the catalytic region was expressed as a truncated proprotein that is part of the regulatory system. tein lacking the membrane anchor, the protein was soluble in the cytosol, and it restored growth to HMG CoA is to render the degradation of HMG CoA reductase Total cellular RNA was isolated by guanidine thiocyanate/cesium sensitive to regulation by sterols (Gil et al., 1985) . In chloride centrifugation (Chirgwin et al., 1979) . Poly(A) ϩ RNA was sterol-deprived CHO cells, the full-length enzyme was isolated with an mRNA Purification Kit (Pharmacia Biotech). Plasmid pSV␤, encoding an SV40 promoter-driven ␤-galactosidase reporter degraded with a half-life of 5 hr. Sterols reduced the halfgene, was obtained from Clontech. An SRE-1-driven luciferase relife to 1.5 hr. In cells expressing the truncated soluble porter plasmid containing, 5Ј to 3Ј, three tandem copies of Repeat catalytic domain, the half-life of the enzyme was greater 2 ϩ 3 of the LDL receptor promoter, the adenovirus E1b TATA box, than 10 hr, and there was no effect of sterols. In more and the luciferase gene was provided to us by Steven McKnight recent studies, Kumagai et al. (1995) have used HMG (Tularik, Inc.) . This reporter plasmid, designated pSRE-Luc, was
CoA reductase-␤-galactosidase fusion proteins to show constructed by PCR amplification of Repeat 2 ϩ 3 of Plasmid K (Briggs et al., 1993) and insertion of the PCR product into pGL2-that several of the membrane-spanning segments are include the ones that resemble the putative membranespanning segments in SCAP.
Cell Culture, Transfection, and Fractionation of Cells
The sequence resemblance between the hydrophobic proteins are regulatory and none is an enzyme. They (1996) and Wall et al. (1995) , who determined the into the SalI-NotI-digested parent vector using the SuperScript propeller. In G i␣1 ␤ 1 ␥ 2 , blades of the WD propeller interact pools of plasmids (approximately 1 ϫ 10 3 independent cDNAs per with the Gi␣1 subunit and the ␥2 subunit, thereby bridging pool) were grown overnight in 50 ml cultures of Luria-Bertani methe heterotrimeric complex (Wall et al., 1995) . It is temptdium. Prior to transfection, plasmid DNA was purified using Qiagening to speculate that the WD repeats of SCAP interact tip 100 columns (Qiagen, Inc.). Pools of cDNAs in pRc/CMV7SB were transfected into 293 cells with and regulate SREBP, the site 1 protease, or both.
simultaneously with cDNAs encoding an SRE-1-driven luciferase Construction of Expression Plasmids A TK promoter-driven expression plasmid encoding an epitopereporter gene (pSRE-Luc) and a control ␤-galactosidase gene driven by an SV40 promoter (pSV␤). On day 0, replicate wells of 6 ϫ 10 4 tagged version of mutant SCAP, designated pTK-HSV-SCAP-T7(D443N), was constructed in two steps: first, pTK-HSV-BP2 (Hua cells/22 mm well were plated in medium A with 10% fetal calf serum. On day 2, duplicate wells of cells were each cotransfected by the et al., 1996) was digested with BspDI and XbaI to isolate a 6 kb fragment containing two tandem copies of the HSV epitope tag calcium phosphate method with an MBS Kit (Stratagene) with the following plasmids: 1.32 g of the cDNA pool of plasmids; 0.2 g upstream of the BspDI site. pCMV-SCAP(D443N) was digested with BstEII and XbaI to isolate a 3.6 kb fragment encoding amino acids of pVA, a plasmid encoding adenovirus VA RNA1, which enhances expression of transfected cDNAs (Yokoyama et al., 1993) ; 0.36 g 151-1276 of SCAP. A pair of primers, 5Ј-GAAATCGATACCCTGACT GAAAGGCTGCGT-3Ј corresponding to amino acids 2-8 and 5Ј-AAC of the SRE-1-driven luciferase reporter construct; and 0.12 g of pSV␤ in a final volume of 200 l. After transfection (3 hr), the cells TTGGCATGGTAGCGCTG-3Ј corresponding to amino acids 241-246, was used to amplify the NH 2-terminus of SCAP by PCR of were washed once with phosphate-buffered saline and fed with 2 ml of medium A supplemented with 10% newborn calf lipoproteinpCMV-SCAP(D443N), using described conditions (Hua et al., 1995) . The resultant PCR product was digested with BspDI and BstEII to deficient serum, 50 M compactin, 50 M sodium mevalonate, 1 g/ml of 25-HC, and 10 g/ml of cholesterol. After 16 hr, the cells isolate a 447 bp fragment. The above three fragments were ligated to generate an intermediate construct encoding an initiator methioin each well were lysed with 250 l of 1X Reporter Lysis Buffer (Promega), and aliquots were used for measurement of luciferase nine, followed by two tandem copies of the HSV epitope tag , followed by two novel amino acids (ID) that correspond (5 l) and ␤-galactosidase (30 l) activities. For luciferase assay, photon production was detected as relative light units in an Optima to the BspDI restriction site, followed by amino acids 2-1276 of SCAP(D443N). Second, the above intermediate construct was di-II Luminometer (MGM Instruments). For ␤-galactosidase assay, hydrolysis of O-nitrophenyl ␤-D-galactopyranoside was detected after gested with BspDI and BstYI to isolate a 3.6 kb fragment containing amino acids 2-1195 of SCAP(D443N). pTK-HSV-BP2-T7, which conincubation for 1 hr at 37ЊC in a Microplate Reader at a wavelength of 405 nm (Bio-Tek Instruments). The amount of luciferase activity tains three tandem copies of the T7 epitope tag sequence at the carboxy-terminus (provided by Elizabeth Duncan), was digested in transfectants (relative light units) was normalized to the amount of ␤-galactosidase activity (O.D. units).
with BspDI and NdeI to isolate a 6 kb fragment that contained the T7 epitope repeats but not the sequence of SREBP-2. A pair The normalized values for luciferase activity (relative light units/ O.D. units), in monolayers transfected with the vast majority of plasof primers, 5Ј-TACAGCAGCAGCAACACAGT-3Ј corresponding to amino acid residues 1057-1063 of SCAP and 5Ј-GCTAGCCATATGA mid cDNA pools, were about 2,000. In a screen of 235 pools of 1,000 cDNAs each, a single pool gave a normalized value approximately GCTGCGTCCAGTTTCTCCAGCACAGA-3Ј corresponding to amino acid residues 1270-1276 of SCAP, was used to amplify the carboxy-5-fold higher than the background value of 2,000 and was considered positive (Figure 3 ). The DNA from this positive pool, number terminus of SCAP. The resulting PCR product was digested with BstYI and NdeI, and a 253 bp fragment encoding amino acids 1196-60, was transformed into E. coli DH5␣ cells to generate multiple pools of approximately 100 independent transformants per pool.
1276 of SCAP was isolated. The three isolated fragments were ligated to generate pTK-HSV-SCAP-T7(D443N). The plasmid pools were transfected into 293 cells, which were assayed for expression of luciferase and ␤-galactosidase activities.
A TK promoter-driven expression plasmid encoding an epitopetagged version of wild-type SCAP, designated pTK-HSV-SCAP-T7, Plasmid DNA from one positive pool was retransformed into E. coli to generate multiple pools of about 10 transformants per pool. These was constructed by replacing the 1.8 kb BstEII-BsmBI fragment of pTK-HSV-SCAP-T7(D443N) encoding amino acids 151-763 with the plasmid pools were transfected into 293 cells. The plasmids from one positive pool were further divided into five cDNAs per pool corresponding fragment from pSCAP (described above). The sequence of codon 443 was confirmed by DNA sequencing to be wildbefore transfection and then assayed. Finally, individual cDNAs were used to transfect 293 cells, and two positive clones were identified, type. A CMV promoter-driven expression plasmid encoding wild-type p28 and p30. Subsequent studies were carried out with clone p30, which encodes the mutant form of SCAP and is hereafter designated SCAP was constructed in three steps: first, pCMV-SCAP(D443N) (described above in "Expression Cloning") was digested with SalIpCMV-SCAP(D443N). A set of two fragments generated from pCMV-SCAP(D443N) after digestion with SalI-NotI, 2.9 kb and 1.3 kb, were DraI, and the resulting 4.1 kb insert containing SCAP(D443N) was subsequently cloned into the XhoI-EcoRV sites of pcDNA3 to genercloned into pBluescript ® II SK(ϩ) and sequenced on both strands with T7/T3 primers or specific internal primers. ate intermediate construct I. Second, intermediate construct I was digested with BamHI-BstEII, and the resulting fragment encoding amino acids 1-150 of SCAP was used to replace the BamHI-BstEII cDNA Cloning of Wild-Type SCAP fragment from pcDNA3-clone 4 (described above) that lacked the A double-stranded bacteriophage library was constructed from poly sequence of the first 56 amino acids of SCAP-wt to generate inter-(A) ϩ RNA isolated from CHO-7 cells using the Directional RH Random mediate construct II. Third, intermediate construct II was digested Primer cDNA Library Construction System (Novagen). cDNAs from with BamHI and BsmBI, and the resulting 2.4 kb fragment was used the first two fractions of the gel filtration column provided in the kit to replace amino acids 1-763 of SCAP(D443N) between SalI-BsmBI were ligated into the EcoRI-HindIII arms of Phage and plated out sites in pCMV-SCAP(D443N), yielding a construct expressing wildon E. coli ER1647. Approximately 5 ϫ 10 5 plaques were transferred type SCAP, designated pCMV-SCAP. The sequence at codon 443 to replicate filters and probed with a 32 P-labeled 2.9 kb SalI-NotI was verified by DNA sequencing. DNA fragment from pCMV-SCAP(D443N). One clone, designated A CMV promoter-driven expression plasmid encoding human clone 4, contained an insert of 3.9 kb and was sequenced on both SREBP-2 was constructed by cloning a 4.1 kb SpeI-XbaI fragment strands. This clone lacked the sequence encoding the first 56 encoding the HSV epitope-tagged SREBP-2 fusion protein of 1157 amino acids of SCAP. Clone 4 was digested with BamHI-PmeI and amino acids from pTK-HSV-BP2 into the EcoRVcloned into the BamHI-EcoRV sites of pcDNA3 (Invitrogen) to generXbaI sites of pcDNA3. This plasmid is designated pCMV-HSV-BP2. ate an intermediate construct, pcDNA3-Clone 4. To construct the entire coding sequence of wild-type SCAP, we amplified the sequence encoding wild-type SCAP from CHO-7 cells by reverse PCR of Genomic DNA and Single-Strand Conformational Polymorphism Analysis transcription-PCR with a primer pair corresponding to nucleotides 5Ј-GACTCAGTCGACAGGGGAAAGGTACCTGCAGA-3Ј from Genomic DNA from wild-type and 25-RA cells was isolated with a DNA extraction kit (Stratagene). Primers flanking the point mutation the 5Ј-untranslated region and 5Ј-CTGAGTTACGTAAGGTCCAAAG AATTGCTGCC-3Ј from the 3Ј-untranslated region of pCMV-SCAP at codon 443 of the SCAP gene were used to amplify genomic DNA by PCR. Single-strand conformational polymorphism analysis of (D443N). The PCR-amplified product was digested with SalI and BsmI to isolate an approximately 500 bp fragment encoding the genomic DNA was carried out as described by Orita et al. (1989) . PCR products were cloned into a pCR TM II vector (Invitrogen) or a first 121 amino acids of SCAP. This fragment was ligated into the BamHI-BsmI site of pcDNA3-Clone 4 to generate a wild-type version pNoTA/T7 vector (5 Prime → 3 Prime, Inc.) and sequenced to verify the mutation. of SCAP, designated pSCAP.
